T1	Participants 49 69	survival in melanoma
T2	Participants 333 455	prognostic significance of SLN metastatic deposits < or = 0.2 mm in patients treated in a referral cancer center in Brazil
T3	Participants 465 596	Patients with stage I/II melanoma, consecutively submitted to a SLN procedure by the same surgeon from 2000 to 2006, were evaluated
T4	Participants 839 901	381 patients who underwent SLN biopsy, 103 (27%) were positive
T5	Participants 907 1027	mean/median Breslow tumor thickness in the overall group was 3.4/2.0 mm and in the SLN positive patients was 5.72/4.0 mm
